These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma? Barr PM Oncology (Williston Park); 2018 Aug; 32(8):404, 407-9. PubMed ID: 30153320 [No Abstract] [Full Text] [Related]
4. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here? Gordon LI Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340 [No Abstract] [Full Text] [Related]
6. Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy. Griffiths R; Gleeson M; Reyes C; Knopf K; Danese M Am J Hematol; 2010 Dec; 85(12):963-7. PubMed ID: 20981680 [No Abstract] [Full Text] [Related]
7. Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients. de Mendonça GR; Brito AB; Rocha RM; Delamain MT; de Andrade Natal R; Soares FA; Colleoni GW; Souza CA; Vassallo J; Lima CS Blood Cancer J; 2016 Aug; 6(8):e464. PubMed ID: 27564462 [No Abstract] [Full Text] [Related]
8. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era. Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321 [TBL] [Abstract][Full Text] [Related]
9. [A case of follicular lymphoma of the duodenum treated with the combined therapy of anti-CD20 antibody and chemotherapy]. Isogai K; Yamamoto E; Yamaoka S; Tarasawa I; Murakami R; Morimoto I; Obata T; Mori M; Endo T; Imai K Nihon Shokakibyo Gakkai Zasshi; 2006 Mar; 103(3):301-9. PubMed ID: 16688961 [No Abstract] [Full Text] [Related]
13. Hematology: The case against rituximab maintenance. Cheson BD Nat Rev Clin Oncol; 2009 Nov; 6(11):622-4. PubMed ID: 19861992 [No Abstract] [Full Text] [Related]
14. Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study. Pauly F; Fjordén K; Leppä S; Holte H; Björkholm M; Fluge Ø; Møller Pedersen L; Eriksson M; Isinger-Ekstrand A; Borrebaeck CA; Jerkeman M; Wingren C Blood Cancer J; 2016 Nov; 6(11):e501. PubMed ID: 27858932 [No Abstract] [Full Text] [Related]
15. A rare case of bilateral chylothorax: a diagnostic challenge--follicular lymphoma versus primary effusion lymphoma. Podder S; Mora M; Patel V; Sivamurthy S BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26282457 [TBL] [Abstract][Full Text] [Related]
16. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas. Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT; Lechowicz MJ; Lonial S; Flowers CR Cancer; 2012 Jul; 118(14):3538-48. PubMed ID: 22535574 [TBL] [Abstract][Full Text] [Related]
17. What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma? Kenkre VP; Kahl BS Cancer J; 2012; 18(5):383-9. PubMed ID: 23006941 [TBL] [Abstract][Full Text] [Related]
18. Impact of age on genetics and treatment efficacy in follicular lymphoma. Alig S; Jurinovic V; Pastore A; Bararia D; Häbe S; Hellmuth JC; Kridel R; Gascoyne R; Schmidt C; Zöllner AK; Buske C; Dreyling M; Unterhalt M; Hiddemann W; Hoster E; Weigert O Haematologica; 2018 Aug; 103(8):e364-e367. PubMed ID: 29545350 [No Abstract] [Full Text] [Related]